{"id":354311,"date":"2025-08-28T12:01:13","date_gmt":"2025-08-28T12:01:13","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-ideaya-biosciences\/"},"modified":"2025-08-28T12:01:13","modified_gmt":"2025-08-28T12:01:13","slug":"how-to-buy-ideaya-biosciences","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/","title":{"rendered":"IDEAYA Biosciences, Inc. (IDYA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; IDEAYA Biosciences, Inc. (IDYA) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334099,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-354311","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"IDEAYA Biosciences, Inc. (IDYA) Hisseleri Nas\u0131l Al\u0131n\u0131r - IDEAYA Biosciences, Inc. (IDYA) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"IDEAYA Biosciences, Inc. (IDYA) Hisseleri Nas\u0131l Al\u0131n\u0131r - IDEAYA Biosciences, Inc. (IDYA) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"IDEAYA Biosciences, Inc. (IDYA) hisseleri nas\u0131l al\u0131n\u0131r ve bu hassas t\u0131p onkoloji \u015firketine nas\u0131l yat\u0131r\u0131m yap\u0131l\u0131r \u00f6\u011frenin. G\u00fcncel hisse performans\u0131n\u0131, riskleri ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"IDEAYA Biosciences, Inc. (IDYA) hisseleri nas\u0131l al\u0131n\u0131r ve bu hassas t\u0131p onkoloji \u015firketine nas\u0131l yat\u0131r\u0131m yap\u0131l\u0131r \u00f6\u011frenin. G\u00fcncel hisse performans\u0131n\u0131, riskleri ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"Kanser tedavisinin gelece\u011fine yat\u0131r\u0131m yapmak m\u0131 istiyorsunuz? IDEAYA Biosciences, hedefe y\u00f6nelik tedavilerin genetik at\u0131l\u0131mlarla bulu\u015ftu\u011fu hassas t\u0131p onkolojisinin \u00f6nc\u00fcs\u00fcd\u00fcr. Bu klinik a\u015famadaki biyoteknoloji \u015firketi, kanser tedavisinde devrim yaratabilir ve ileri g\u00f6r\u00fc\u015fl\u00fc yat\u0131r\u0131mc\u0131lar i\u00e7in heyecan verici bir f\u0131rsat sunar. IDYA hissesinin neden dikkatinizi hak etti\u011fini ve bu t\u0131bbi yenilik hikayesinin bir par\u00e7as\u0131 nas\u0131l olabilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Kanser tedavisinin gelece\u011fine yat\u0131r\u0131m yapmak m\u0131 istiyorsunuz? IDEAYA Biosciences, hedefe y\u00f6nelik tedavilerin genetik at\u0131l\u0131mlarla bulu\u015ftu\u011fu hassas t\u0131p onkolojisinin \u00f6nc\u00fcs\u00fcd\u00fcr. Bu klinik a\u015famadaki biyoteknoloji \u015firketi, kanser tedavisinde devrim yaratabilir ve ileri g\u00f6r\u00fc\u015fl\u00fc yat\u0131r\u0131mc\u0131lar i\u00e7in heyecan verici bir f\u0131rsat sunar. IDYA hissesinin neden dikkatinizi hak etti\u011fini ve bu t\u0131bbi yenilik hikayesinin bir par\u00e7as\u0131 nas\u0131l olabilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 IDEAYA Biosciences Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2> <p>28 A\u011fustos 2025 itibar\u0131yla, IDEAYA Biosciences (IDYA) NASDAQ borsas\u0131nda <strong>25,00 $<\/strong> seviyesinden i\u015flem g\u00f6rmektedir. Hisse, 52 haftal\u0131k en d\u00fc\u015f\u00fck seviyesi olan 13,45 $'dan toparlanarak son \u00fc\u00e7 ayda %29,35'lik g\u00fc\u00e7l\u00fc bir ivme g\u00f6stermi\u015ftir.<\/p> <p><strong>Takviminize Not Edin: 3 Kas\u0131m 2025<\/strong>, her IDYA yat\u0131r\u0131mc\u0131s\u0131n\u0131n takip etmesi gereken bir sonraki kritik tarihtir. \u015eirketin 2025 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 bu tarih, hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilecek bir kataliz\u00f6r olabilir.<\/p> <h3>Kazan\u00e7 Raporlar\u0131n\u0131n IDYA Hissesi \u00dczerindeki Etkisi<\/h3> <p>Son tarihleri inceledi\u011fimizde net bir desen ortaya \u00e7\u0131k\u0131yor. IDEAYA, 5 A\u011fustos 2025'te 2025 2. \u00e7eyrek sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klad\u0131\u011f\u0131nda, piyasa 992 milyon $ nakit pozisyonu ve g\u00fc\u00e7l\u00fc klinik deneme ilerlemesi nedeniyle olumlu tepki verdi. Hisse, bu a\u00e7\u0131klamadan sonraki iki hafta i\u00e7inde yakla\u015f\u0131k %9 de\u011fer kazand\u0131.<\/p> <p>\u00d6nceki kazan\u00e7 olaylar\u0131 benzer desenler g\u00f6steriyor:<\/p> <ul> <li><strong>2025 May\u0131s 1. \u00c7eyrek Sonu\u00e7lar\u0131<\/strong>: 1,05 milyar $ nakit pozisyonu a\u00e7\u0131klamas\u0131n\u0131n ard\u0131ndan hisse %6 artt\u0131<\/li> <li><strong>2025 \u015eubat Y\u0131ll\u0131k Raporu<\/strong>: Pipeline geli\u015fmelerinin vurgulanmas\u0131n\u0131n ard\u0131ndan %8 olumlu hareket<\/li> <li><strong>2024 Kas\u0131m G\u00fcncellemesi<\/strong>: Klinik deneme kay\u0131t kilometre ta\u015flar\u0131n\u0131n ard\u0131ndan m\u00fctevaz\u0131 %3 art\u0131\u015f<\/li> <\/ul> <p>Desen a\u00e7\u0131k\u2014olumlu klinik g\u00fcncellemeler ve g\u00fc\u00e7l\u00fc finansal konum, bu biyoteknoloji yenilik\u00e7isine yat\u0131r\u0131mc\u0131 g\u00fcvenini s\u00fcrekli art\u0131r\u0131yor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Dalgalanmalardan \u0130stikrara<\/h2> <p>IDEAYA hissesi son alt\u0131 ayda yat\u0131r\u0131mc\u0131lar\u0131 olduk\u00e7a hareketli bir yolculu\u011fa \u00e7\u0131kard\u0131. \u0130\u015fte yolculu\u011fun geli\u015fimi:<\/p> <p><strong>Mart 2025<\/strong>: Piyasa belirsizli\u011fi sonras\u0131 yakla\u015f\u0131k 19,50 $ seviyesinde i\u015flem g\u00f6rd\u00fc<br\/> <strong>Nisan 2025<\/strong>: Faz 2 olumlu veri a\u00e7\u0131klamalar\u0131yla 22,80 $'a y\u00fckseldi<br\/> <strong>May\u0131s 2025<\/strong>: 1. \u00e7eyrek kazan\u00e7lar\u0131 ve nakit runway rehberli\u011fi sonras\u0131 25,50 $'a t\u0131rmand\u0131<br\/> <strong>Haziran 2025<\/strong>: Yaz d\u00f6nemi i\u015flemlerinde 24,20 $ civar\u0131nda konsolide oldu<br\/> <strong>Temmuz 2025<\/strong>: FDA \u00f6nc\u00fc tedavi tan\u0131m\u0131 haberleriyle 26,80 $'a ula\u015ft\u0131<br\/> <strong>A\u011fustos 2025<\/strong>: \u015eu anda 25,00 $ seviyesinde ve haftal\u0131k volatilitesi sadece %6,2 ile stabil<\/p> <p>Bu toparlanmay\u0131 ne tetikliyor? Birka\u00e7 fakt\u00f6r:<\/p> <ul> <li>Anahtar klinik denemelerde 350'den fazla hastan\u0131n ba\u015far\u0131l\u0131 kayd\u0131<\/li> <li>Darovasertib i\u00e7in FDA \u00f6nc\u00fc tedavi tan\u0131m\u0131<\/li> <li>2029'a kadar operasyonlar\u0131 finanse eden g\u00fc\u00e7l\u00fc nakit pozisyonu<\/li> <li>2025 sonlar\u0131nda planlanan birden fazla IND ba\u015fvurusu<\/li> <\/ul> <p>Hissenin d\u00fc\u015f\u00fck beta de\u011feri 0,086, daha geni\u015f piyasa dalgalanmalar\u0131ndan ba\u011f\u0131ms\u0131z hareket etti\u011fi anlam\u0131na gelir\u2014biyoteknolojiye maruz kalmak isteyen ancak a\u015f\u0131r\u0131 piyasa korelasyonu istemeyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist konsens\u00fcs\u00fc ve klinik kilometre ta\u015flar\u0131na dayanarak beklentiler \u015funlard\u0131r:<\/p> <p><strong>2025 Y\u0131l Sonu Hedefi<\/strong>: 30-35 $ aral\u0131\u011f\u0131 (mevcut seviyelerden %20-40 y\u00fckseli\u015f)<br\/> Analistler \u00f6n\u00fcm\u00fczdeki \u00fc\u00e7 ayda %24,24 art\u0131\u015f \u00f6ng\u00f6r\u00fcyor, %90 olas\u0131l\u0131k aral\u0131\u011f\u0131 26,09-30,95 $ aras\u0131nda. 8 Eyl\u00fcl'deki yakla\u015fan Ar-Ge G\u00fcn\u00fc \u00f6nemli bir kataliz\u00f6r olabilir.<\/p> <p><strong>2026 Projeksiyonu<\/strong>: Ortalama 45-50 $ hedef<br\/> Birden fazla klinik sonu\u00e7 ve potansiyel d\u00fczenleyici ba\u015fvurularla 2026 at\u0131l\u0131m y\u0131l\u0131 olabilir. Muhafazakar tahminler 47,94 $ iken iyimser tahminler 80,38 $'a kadar \u00e7\u0131k\u0131yor.<\/p> <p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 60-70 $ aral\u0131\u011f\u0131<br\/> 2028'e kadar birka\u00e7 \u00f6nemli program ticarile\u015fmi\u015f veya ge\u00e7 a\u015fama geli\u015ftirmede olabilir, bu da \u00f6nemli de\u011fer yarat\u0131m\u0131 sa\u011flar.<\/p> <p><strong>2030 Vizyonu<\/strong>: 70-85 $ potansiyel<br\/> Uzun vadeli analistler, \u015firketin klinik a\u015famadan ticari a\u015famaya d\u00f6n\u00fc\u015fmesiyle 2030'da 73,44 $ seviyesini \u00f6ng\u00f6r\u00fcyor.<\/p> <p><strong>Karar<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Sa\u011flam nakit runway, \u00e7oklu klinik kataliz\u00f6rler ve s\u0131n\u0131f\u0131n\u0131n ilk pipeline kombinasyonu, IDYA'y\u0131 mevcut seviyelerde cazip bir yat\u0131r\u0131m yap\u0131yor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Biyoteknoloji hisseleri klinik verilere ba\u011fl\u0131d\u0131r. Devam eden denemelerden olumsuz sonu\u00e7lar hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir.<\/li> <li><strong>D\u00fczenleyici Engeller<\/strong>: FDA onaylar\u0131 asla garanti de\u011fildir. Gecikmeler veya reddedilmeler geli\u015ftirme takvimlerini geriye \u00e7ekebilir.<\/li> <li><strong>Piyasa Volatilitesi<\/strong>: IDYA d\u00fc\u015f\u00fck beta de\u011ferine sahip olsa da, biyoteknoloji sekt\u00f6r\u00fc duyarl\u0131l\u0131\u011f\u0131 makroekonomik fakt\u00f6rlere ba\u011fl\u0131 olarak h\u0131zla de\u011fi\u015febilir.<\/li> <li><strong>Rekabet<\/strong>: Di\u011fer \u015firketler benzer hassas t\u0131p yakla\u015f\u0131mlar\u0131 geli\u015ftiriyor, ancak IDEAYA'n\u0131n sentetik letalite odaklanmas\u0131 baz\u0131 farkl\u0131l\u0131klar sa\u011flar.<\/li> <\/ul> <h3>2025-2026 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Nakit Runway Avantaj\u0131<\/strong>: 1,05 milyar $ nakit pozisyonu ile 2029'a kadar operasyonlar\u0131 finanse eden IDEAYA, seyrek g\u00f6r\u00fclen bir seyrelme riski avantaj\u0131na sahiptir.<\/li> <li><strong>\u00c7oklu Kataliz\u00f6rler<\/strong>: \u015eirket, y\u0131l sonuna kadar beklenen birka\u00e7 veri a\u00e7\u0131klamas\u0131yla 300'den fazla hastay\u0131 tedavi etti.<\/li> <li><strong>FDA \u00d6ncelikli Stat\u00fc<\/strong>: Darovasertib'in \u00f6nc\u00fc tedavi tan\u0131m\u0131 d\u00fczenleyici incelemeyi h\u0131zland\u0131r\u0131r ve onay olas\u0131l\u0131\u011f\u0131n\u0131 art\u0131r\u0131r.<\/li> <li><strong>Sekt\u00f6r R\u00fczgarlar\u0131<\/strong>: Hassas t\u0131p onkolojisi b\u00fcy\u00fck bir b\u00fcy\u00fcme ya\u015f\u0131yor ve pazar\u0131n 2030'da 100 milyar $'\u0131 a\u015fmas\u0131 bekleniyor.<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %2-3'\u00fcnden fazla olmayan bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n. Biyoteknoloji yat\u0131r\u0131m\u0131 sab\u0131r ve risk y\u00f6netimi gerektirir.<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: T\u00fcm al\u0131m\u0131 tek seferde yapmak yerine, giri\u015f fiyat\u0131n\u0131z\u0131 ortalamak i\u00e7in al\u0131mlar\u0131n\u0131z\u0131 birka\u00e7 haftaya yaymay\u0131 d\u00fc\u015f\u00fcn\u00fcn.<\/li> <li><strong>Fiyat Uyar\u0131lar\u0131 Kurun<\/strong>: Optimal giri\u015f noktalar\u0131 i\u00e7in 23 $ (destek) ve 27 $ (diren\u00e7) seviyelerini takip edin.<\/li> <li><strong>Bilimi Takip Edin<\/strong>: G\u00fcnl\u00fck fiyat hareketleri yerine klinik deneme g\u00fcncellemelerini izleyin. Ger\u00e7ek de\u011fer s\u00fcr\u00fcc\u00fcleri t\u0131bbi at\u0131l\u0131mlar, piyasa duyarl\u0131l\u0131\u011f\u0131 de\u011fil.<\/li> <\/ol> <p>Ve favori t\u00fcccar bilgeli\u011fim: \"Biyoteknolojiye yat\u0131r\u0131m yapmak, boya kurumas\u0131n\u0131 izlemek gibidir\u2014ama bazen boya kanseri iyile\u015ftirir ve sizi zengin eder. Sab\u0131r sadece bir erdem de\u011fil, ayn\u0131 zamanda bir k\u00e2r stratejisidir.\"<\/p> <h2>\u2705 IDEAYA Biosciences, Inc. (IDYA) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NASDAQ listeli hisseleri sunan ve makul komisyon \u00fccretlerine sahip oldu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 A\u00e7\u0131n ve Fonlay\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n\u2014100 $ bile ba\u015flaman\u0131z i\u00e7in yeterlidir<\/td><\/tr> <tr><td>3<\/td><td>\"IDYA\" Aray\u0131n<\/td><td>Do\u011fru menkul k\u0131ymeti bulmak i\u00e7in sadece \u015firket ad\u0131 de\u011fil, borsa sembol\u00fcn\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in piyasa emirleri yerine limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve Onaylay\u0131n<\/td><td>Miktar, fiyat ve toplam maliyet dahil olmak \u00fczere emir detaylar\u0131n\u0131 \u00e7ift kontrol edin<\/td><\/tr> <tr><td>6<\/td><td>Pozisyonunuzu \u0130zleyin<\/td><td>Kazan\u00e7 tarihleri ve klinik deneme duyurular\u0131 i\u00e7in uyar\u0131lar kurun<\/td><\/tr> <tr><td>7<\/td><td>Temett\u00fc Yeniden Yat\u0131r\u0131m\u0131n\u0131 D\u00fc\u015f\u00fcn\u00fcn<\/td><td>IDYA \u015fu anda temett\u00fc \u00f6demese de, gelecekteki b\u00fcy\u00fcme i\u00e7in plan yap\u0131n<\/td><\/tr> <tr><td>8<\/td><td>Performans\u0131 Takip Edin<\/td><td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 zaman i\u00e7inde izlemek i\u00e7in portf\u00f6y takip ara\u00e7lar\u0131 kullan\u0131n<\/td><\/tr> <tr><td>9<\/td><td>Bilgili Kal\u0131n<\/td><td>\u015eirket bas\u0131n b\u00fcltenleri ve klinik g\u00fcncellemeleri d\u00fczenli olarak takip edin<\/td><\/tr> <tr><td>10<\/td><td>Stratejinizi \u00dc\u00e7 Ayl\u0131k G\u00f6zden Ge\u00e7irin<\/td><td>Yeni geli\u015fmeler ve genel portf\u00f6y hedeflerine g\u00f6re pozisyonunuzu yeniden de\u011ferlendirin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden \u00d6ne \u00c7\u0131k\u0131yor<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, IDYA gibi hisselere eri\u015fimi kolayla\u015ft\u0131ran birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum Giri\u015f Engeli<\/strong>: Sadece 5 $ minimum depozito ile, \u00f6nemli sermaye taahh\u00fcd\u00fc olmadan umut vadeden \u015firketlerde pozisyonlar olu\u015fturmaya ba\u015flayabilirsiniz.<\/li> <li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Platformun 1 dakikal\u0131k KYC s\u00fcreci, tek bir belge ile kay\u0131t sonras\u0131 hemen i\u015flem yapmaya ba\u015flaman\u0131z\u0131 sa\u011flar.<\/li> <li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong>: Kripto paralar, e-c\u00fczdanlar ve geleneksel banka transferleri dahil 100'den fazla para \u00e7ekme y\u00f6ntemi, k\u00e2rlar\u0131n\u0131z\u0131 y\u00f6netmede esneklik sunar.<\/li> <li><strong>E\u011fitim Kaynaklar\u0131<\/strong>: Pocket Option blogu, temel ticaretin \u00f6tesinde bilgi edinmek isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in de\u011ferli i\u00e7g\u00f6r\u00fcler sa\u011flar.<\/li> <\/ul> <h2>\ud83c\udf0d 2025'te IDEAYA Biosciences: Hassas T\u0131p \u00d6nc\u00fcs\u00fc<\/h2> <p>IDEAYA Biosciences, t\u0131bbi devrimin \u00f6n saflar\u0131nda yer almaktad\u0131r. \u015eirket, kanser h\u00fccrelerini geni\u015f toksisite yerine genetik zay\u0131fl\u0131klar\u0131na g\u00f6re hedef alan yenilik\u00e7i bir yakla\u015f\u0131m olan sentetik letaliteye uzmanla\u015fm\u0131\u015ft\u0131r. Klinik denemelerinde 300'den fazla hasta tedavi edilmi\u015f ve birden fazla program e\u015f zamanl\u0131 olarak ilerlemektedir; IDEAYA onkoloji tedavisinin gelece\u011fini temsil eder.<\/p> <p>\u015eirketin 1,05 milyar $ nakit pozisyonu, klinik a\u015famadaki bir biyoteknoloji i\u00e7in e\u015fi g\u00f6r\u00fclmemi\u015f finansal istikrar sa\u011flar ve 2029'a kadar operasyonlar\u0131 finanse eder. Bu, bir\u00e7ok yeni ila\u00e7 \u015firketini etkileyen tipik seyrelme riskini ortadan kald\u0131r\u0131r.<\/p> <p><strong>\u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: 2025'te 10. y\u0131l d\u00f6n\u00fcmlerini kutlamak i\u00e7in IDEAYA, G\u00fcney San Francisco merkezinde ger\u00e7ek zamanl\u0131 klinik deneme verilerini g\u00f6steren interaktif dijital duvarlar kurdu\u2014bilim insanlar\u0131n\u0131n d\u00fcnya \u00e7ap\u0131ndan gelen hasta yan\u0131tlar\u0131n\u0131 izleyerek kanser ara\u015ft\u0131rmas\u0131n\u0131n nas\u0131l geli\u015fti\u011fini adeta g\u00f6zleriyle g\u00f6rmelerini sa\u011fl\u0131yor.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 IDEAYA Biosciences Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2>\n<p>28 A\u011fustos 2025 itibar\u0131yla, IDEAYA Biosciences (IDYA) NASDAQ borsas\u0131nda <strong>25,00 $<\/strong> seviyesinden i\u015flem g\u00f6rmektedir. Hisse, 52 haftal\u0131k en d\u00fc\u015f\u00fck seviyesi olan 13,45 $&#8217;dan toparlanarak son \u00fc\u00e7 ayda %29,35&#8217;lik g\u00fc\u00e7l\u00fc bir ivme g\u00f6stermi\u015ftir.<\/p>\n<p><strong>Takviminize Not Edin: 3 Kas\u0131m 2025<\/strong>, her IDYA yat\u0131r\u0131mc\u0131s\u0131n\u0131n takip etmesi gereken bir sonraki kritik tarihtir. \u015eirketin 2025 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 bu tarih, hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilecek bir kataliz\u00f6r olabilir.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131n\u0131n IDYA Hissesi \u00dczerindeki Etkisi<\/h3>\n<p>Son tarihleri inceledi\u011fimizde net bir desen ortaya \u00e7\u0131k\u0131yor. IDEAYA, 5 A\u011fustos 2025&#8217;te 2025 2. \u00e7eyrek sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klad\u0131\u011f\u0131nda, piyasa 992 milyon $ nakit pozisyonu ve g\u00fc\u00e7l\u00fc klinik deneme ilerlemesi nedeniyle olumlu tepki verdi. Hisse, bu a\u00e7\u0131klamadan sonraki iki hafta i\u00e7inde yakla\u015f\u0131k %9 de\u011fer kazand\u0131.<\/p>\n<p>\u00d6nceki kazan\u00e7 olaylar\u0131 benzer desenler g\u00f6steriyor:<\/p>\n<ul>\n<li><strong>2025 May\u0131s 1. \u00c7eyrek Sonu\u00e7lar\u0131<\/strong>: 1,05 milyar $ nakit pozisyonu a\u00e7\u0131klamas\u0131n\u0131n ard\u0131ndan hisse %6 artt\u0131<\/li>\n<li><strong>2025 \u015eubat Y\u0131ll\u0131k Raporu<\/strong>: Pipeline geli\u015fmelerinin vurgulanmas\u0131n\u0131n ard\u0131ndan %8 olumlu hareket<\/li>\n<li><strong>2024 Kas\u0131m G\u00fcncellemesi<\/strong>: Klinik deneme kay\u0131t kilometre ta\u015flar\u0131n\u0131n ard\u0131ndan m\u00fctevaz\u0131 %3 art\u0131\u015f<\/li>\n<\/ul>\n<p>Desen a\u00e7\u0131k\u2014olumlu klinik g\u00fcncellemeler ve g\u00fc\u00e7l\u00fc finansal konum, bu biyoteknoloji yenilik\u00e7isine yat\u0131r\u0131mc\u0131 g\u00fcvenini s\u00fcrekli art\u0131r\u0131yor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Dalgalanmalardan \u0130stikrara<\/h2>\n<p>IDEAYA hissesi son alt\u0131 ayda yat\u0131r\u0131mc\u0131lar\u0131 olduk\u00e7a hareketli bir yolculu\u011fa \u00e7\u0131kard\u0131. \u0130\u015fte yolculu\u011fun geli\u015fimi:<\/p>\n<p><strong>Mart 2025<\/strong>: Piyasa belirsizli\u011fi sonras\u0131 yakla\u015f\u0131k 19,50 $ seviyesinde i\u015flem g\u00f6rd\u00fc<br \/> <strong>Nisan 2025<\/strong>: Faz 2 olumlu veri a\u00e7\u0131klamalar\u0131yla 22,80 $&#8217;a y\u00fckseldi<br \/> <strong>May\u0131s 2025<\/strong>: 1. \u00e7eyrek kazan\u00e7lar\u0131 ve nakit runway rehberli\u011fi sonras\u0131 25,50 $&#8217;a t\u0131rmand\u0131<br \/> <strong>Haziran 2025<\/strong>: Yaz d\u00f6nemi i\u015flemlerinde 24,20 $ civar\u0131nda konsolide oldu<br \/> <strong>Temmuz 2025<\/strong>: FDA \u00f6nc\u00fc tedavi tan\u0131m\u0131 haberleriyle 26,80 $&#8217;a ula\u015ft\u0131<br \/> <strong>A\u011fustos 2025<\/strong>: \u015eu anda 25,00 $ seviyesinde ve haftal\u0131k volatilitesi sadece %6,2 ile stabil<\/p>\n<p>Bu toparlanmay\u0131 ne tetikliyor? Birka\u00e7 fakt\u00f6r:<\/p>\n<ul>\n<li>Anahtar klinik denemelerde 350&#8217;den fazla hastan\u0131n ba\u015far\u0131l\u0131 kayd\u0131<\/li>\n<li>Darovasertib i\u00e7in FDA \u00f6nc\u00fc tedavi tan\u0131m\u0131<\/li>\n<li>2029&#8217;a kadar operasyonlar\u0131 finanse eden g\u00fc\u00e7l\u00fc nakit pozisyonu<\/li>\n<li>2025 sonlar\u0131nda planlanan birden fazla IND ba\u015fvurusu<\/li>\n<\/ul>\n<p>Hissenin d\u00fc\u015f\u00fck beta de\u011feri 0,086, daha geni\u015f piyasa dalgalanmalar\u0131ndan ba\u011f\u0131ms\u0131z hareket etti\u011fi anlam\u0131na gelir\u2014biyoteknolojiye maruz kalmak isteyen ancak a\u015f\u0131r\u0131 piyasa korelasyonu istemeyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist konsens\u00fcs\u00fc ve klinik kilometre ta\u015flar\u0131na dayanarak beklentiler \u015funlard\u0131r:<\/p>\n<p><strong>2025 Y\u0131l Sonu Hedefi<\/strong>: 30-35 $ aral\u0131\u011f\u0131 (mevcut seviyelerden %20-40 y\u00fckseli\u015f)<br \/> Analistler \u00f6n\u00fcm\u00fczdeki \u00fc\u00e7 ayda %24,24 art\u0131\u015f \u00f6ng\u00f6r\u00fcyor, %90 olas\u0131l\u0131k aral\u0131\u011f\u0131 26,09-30,95 $ aras\u0131nda. 8 Eyl\u00fcl&#8217;deki yakla\u015fan Ar-Ge G\u00fcn\u00fc \u00f6nemli bir kataliz\u00f6r olabilir.<\/p>\n<p><strong>2026 Projeksiyonu<\/strong>: Ortalama 45-50 $ hedef<br \/> Birden fazla klinik sonu\u00e7 ve potansiyel d\u00fczenleyici ba\u015fvurularla 2026 at\u0131l\u0131m y\u0131l\u0131 olabilir. Muhafazakar tahminler 47,94 $ iken iyimser tahminler 80,38 $&#8217;a kadar \u00e7\u0131k\u0131yor.<\/p>\n<p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 60-70 $ aral\u0131\u011f\u0131<br \/> 2028&#8217;e kadar birka\u00e7 \u00f6nemli program ticarile\u015fmi\u015f veya ge\u00e7 a\u015fama geli\u015ftirmede olabilir, bu da \u00f6nemli de\u011fer yarat\u0131m\u0131 sa\u011flar.<\/p>\n<p><strong>2030 Vizyonu<\/strong>: 70-85 $ potansiyel<br \/> Uzun vadeli analistler, \u015firketin klinik a\u015famadan ticari a\u015famaya d\u00f6n\u00fc\u015fmesiyle 2030&#8217;da 73,44 $ seviyesini \u00f6ng\u00f6r\u00fcyor.<\/p>\n<p><strong>Karar<\/strong>: Uzun vadeli yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Sa\u011flam nakit runway, \u00e7oklu klinik kataliz\u00f6rler ve s\u0131n\u0131f\u0131n\u0131n ilk pipeline kombinasyonu, IDYA&#8217;y\u0131 mevcut seviyelerde cazip bir yat\u0131r\u0131m yap\u0131yor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Klinik Deneme Ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Biyoteknoloji hisseleri klinik verilere ba\u011fl\u0131d\u0131r. Devam eden denemelerden olumsuz sonu\u00e7lar hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkileyebilir.<\/li>\n<li><strong>D\u00fczenleyici Engeller<\/strong>: FDA onaylar\u0131 asla garanti de\u011fildir. Gecikmeler veya reddedilmeler geli\u015ftirme takvimlerini geriye \u00e7ekebilir.<\/li>\n<li><strong>Piyasa Volatilitesi<\/strong>: IDYA d\u00fc\u015f\u00fck beta de\u011ferine sahip olsa da, biyoteknoloji sekt\u00f6r\u00fc duyarl\u0131l\u0131\u011f\u0131 makroekonomik fakt\u00f6rlere ba\u011fl\u0131 olarak h\u0131zla de\u011fi\u015febilir.<\/li>\n<li><strong>Rekabet<\/strong>: Di\u011fer \u015firketler benzer hassas t\u0131p yakla\u015f\u0131mlar\u0131 geli\u015ftiriyor, ancak IDEAYA&#8217;n\u0131n sentetik letalite odaklanmas\u0131 baz\u0131 farkl\u0131l\u0131klar sa\u011flar.<\/li>\n<\/ul>\n<h3>2025-2026 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Nakit Runway Avantaj\u0131<\/strong>: 1,05 milyar $ nakit pozisyonu ile 2029&#8217;a kadar operasyonlar\u0131 finanse eden IDEAYA, seyrek g\u00f6r\u00fclen bir seyrelme riski avantaj\u0131na sahiptir.<\/li>\n<li><strong>\u00c7oklu Kataliz\u00f6rler<\/strong>: \u015eirket, y\u0131l sonuna kadar beklenen birka\u00e7 veri a\u00e7\u0131klamas\u0131yla 300&#8217;den fazla hastay\u0131 tedavi etti.<\/li>\n<li><strong>FDA \u00d6ncelikli Stat\u00fc<\/strong>: Darovasertib&#8217;in \u00f6nc\u00fc tedavi tan\u0131m\u0131 d\u00fczenleyici incelemeyi h\u0131zland\u0131r\u0131r ve onay olas\u0131l\u0131\u011f\u0131n\u0131 art\u0131r\u0131r.<\/li>\n<li><strong>Sekt\u00f6r R\u00fczgarlar\u0131<\/strong>: Hassas t\u0131p onkolojisi b\u00fcy\u00fck bir b\u00fcy\u00fcme ya\u015f\u0131yor ve pazar\u0131n 2030&#8217;da 100 milyar $&#8217;\u0131 a\u015fmas\u0131 bekleniyor.<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong>: Toplam portf\u00f6y\u00fcn\u00fcz\u00fcn %2-3&#8217;\u00fcnden fazla olmayan bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n. Biyoteknoloji yat\u0131r\u0131m\u0131 sab\u0131r ve risk y\u00f6netimi gerektirir.<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: T\u00fcm al\u0131m\u0131 tek seferde yapmak yerine, giri\u015f fiyat\u0131n\u0131z\u0131 ortalamak i\u00e7in al\u0131mlar\u0131n\u0131z\u0131 birka\u00e7 haftaya yaymay\u0131 d\u00fc\u015f\u00fcn\u00fcn.<\/li>\n<li><strong>Fiyat Uyar\u0131lar\u0131 Kurun<\/strong>: Optimal giri\u015f noktalar\u0131 i\u00e7in 23 $ (destek) ve 27 $ (diren\u00e7) seviyelerini takip edin.<\/li>\n<li><strong>Bilimi Takip Edin<\/strong>: G\u00fcnl\u00fck fiyat hareketleri yerine klinik deneme g\u00fcncellemelerini izleyin. Ger\u00e7ek de\u011fer s\u00fcr\u00fcc\u00fcleri t\u0131bbi at\u0131l\u0131mlar, piyasa duyarl\u0131l\u0131\u011f\u0131 de\u011fil.<\/li>\n<\/ol>\n<p>Ve favori t\u00fcccar bilgeli\u011fim: &#8220;Biyoteknolojiye yat\u0131r\u0131m yapmak, boya kurumas\u0131n\u0131 izlemek gibidir\u2014ama bazen boya kanseri iyile\u015ftirir ve sizi zengin eder. Sab\u0131r sadece bir erdem de\u011fil, ayn\u0131 zamanda bir k\u00e2r stratejisidir.&#8221;<\/p>\n<h2>\u2705 IDEAYA Biosciences, Inc. (IDYA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ listeli hisseleri sunan ve makul komisyon \u00fccretlerine sahip oldu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 A\u00e7\u0131n ve Fonlay\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n\u2014100 $ bile ba\u015flaman\u0131z i\u00e7in yeterlidir<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;IDYA&#8221; Aray\u0131n<\/td>\n<td>Do\u011fru menkul k\u0131ymeti bulmak i\u00e7in sadece \u015firket ad\u0131 de\u011fil, borsa sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in piyasa emirleri yerine limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve Onaylay\u0131n<\/td>\n<td>Miktar, fiyat ve toplam maliyet dahil olmak \u00fczere emir detaylar\u0131n\u0131 \u00e7ift kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonunuzu \u0130zleyin<\/td>\n<td>Kazan\u00e7 tarihleri ve klinik deneme duyurular\u0131 i\u00e7in uyar\u0131lar kurun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Temett\u00fc Yeniden Yat\u0131r\u0131m\u0131n\u0131 D\u00fc\u015f\u00fcn\u00fcn<\/td>\n<td>IDYA \u015fu anda temett\u00fc \u00f6demese de, gelecekteki b\u00fcy\u00fcme i\u00e7in plan yap\u0131n<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Performans\u0131 Takip Edin<\/td>\n<td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 zaman i\u00e7inde izlemek i\u00e7in portf\u00f6y takip ara\u00e7lar\u0131 kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Bilgili Kal\u0131n<\/td>\n<td>\u015eirket bas\u0131n b\u00fcltenleri ve klinik g\u00fcncellemeleri d\u00fczenli olarak takip edin<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Stratejinizi \u00dc\u00e7 Ayl\u0131k G\u00f6zden Ge\u00e7irin<\/td>\n<td>Yeni geli\u015fmeler ve genel portf\u00f6y hedeflerine g\u00f6re pozisyonunuzu yeniden de\u011ferlendirin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden \u00d6ne \u00c7\u0131k\u0131yor<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option, IDYA gibi hisselere eri\u015fimi kolayla\u015ft\u0131ran birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum Giri\u015f Engeli<\/strong>: Sadece 5 $ minimum depozito ile, \u00f6nemli sermaye taahh\u00fcd\u00fc olmadan umut vadeden \u015firketlerde pozisyonlar olu\u015fturmaya ba\u015flayabilirsiniz.<\/li>\n<li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Platformun 1 dakikal\u0131k KYC s\u00fcreci, tek bir belge ile kay\u0131t sonras\u0131 hemen i\u015flem yapmaya ba\u015flaman\u0131z\u0131 sa\u011flar.<\/li>\n<li><strong>\u00c7e\u015fitli Para \u00c7ekme Se\u00e7enekleri<\/strong>: Kripto paralar, e-c\u00fczdanlar ve geleneksel banka transferleri dahil 100&#8217;den fazla para \u00e7ekme y\u00f6ntemi, k\u00e2rlar\u0131n\u0131z\u0131 y\u00f6netmede esneklik sunar.<\/li>\n<li><strong>E\u011fitim Kaynaklar\u0131<\/strong>: Pocket Option blogu, temel ticaretin \u00f6tesinde bilgi edinmek isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in de\u011ferli i\u00e7g\u00f6r\u00fcler sa\u011flar.<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025&#8217;te IDEAYA Biosciences: Hassas T\u0131p \u00d6nc\u00fcs\u00fc<\/h2>\n<p>IDEAYA Biosciences, t\u0131bbi devrimin \u00f6n saflar\u0131nda yer almaktad\u0131r. \u015eirket, kanser h\u00fccrelerini geni\u015f toksisite yerine genetik zay\u0131fl\u0131klar\u0131na g\u00f6re hedef alan yenilik\u00e7i bir yakla\u015f\u0131m olan sentetik letaliteye uzmanla\u015fm\u0131\u015ft\u0131r. Klinik denemelerinde 300&#8217;den fazla hasta tedavi edilmi\u015f ve birden fazla program e\u015f zamanl\u0131 olarak ilerlemektedir; IDEAYA onkoloji tedavisinin gelece\u011fini temsil eder.<\/p>\n<p>\u015eirketin 1,05 milyar $ nakit pozisyonu, klinik a\u015famadaki bir biyoteknoloji i\u00e7in e\u015fi g\u00f6r\u00fclmemi\u015f finansal istikrar sa\u011flar ve 2029&#8217;a kadar operasyonlar\u0131 finanse eder. Bu, bir\u00e7ok yeni ila\u00e7 \u015firketini etkileyen tipik seyrelme riskini ortadan kald\u0131r\u0131r.<\/p>\n<p><strong>\u0130lgin\u00e7 Bir Ger\u00e7ek<\/strong>: 2025&#8217;te 10. y\u0131l d\u00f6n\u00fcmlerini kutlamak i\u00e7in IDEAYA, G\u00fcney San Francisco merkezinde ger\u00e7ek zamanl\u0131 klinik deneme verilerini g\u00f6steren interaktif dijital duvarlar kurdu\u2014bilim insanlar\u0131n\u0131n d\u00fcnya \u00e7ap\u0131ndan gelen hasta yan\u0131tlar\u0131n\u0131 izleyerek kanser ara\u015ft\u0131rmas\u0131n\u0131n nas\u0131l geli\u015fti\u011fini adeta g\u00f6zleriyle g\u00f6rmelerini sa\u011fl\u0131yor.<\/p>\n"},"faq":[{"question":"IDEAYA Biosciences hisseleri nereden al\u0131nabilir?","answer":"IDEAYA Biosciences hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden IDYA sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"IDEAYA Biosciences hissesi i\u00e7in riskler nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, d\u00fczenleyici onay gecikmeleri, piyasa volatilitesi ve sekt\u00f6rdeki rekabet yer almaktad\u0131r."},{"question":"IDEAYA Biosciences'in finansal durumu nas\u0131l?","answer":"\u015eirketin 1,05 milyar $ nakit pozisyonu bulunmakta olup, bu finansal istikrar 2029 y\u0131l\u0131na kadar operasyonlar\u0131 desteklemektedir."},{"question":"Yeni ba\u015flayan biri IDEAYA hissesi al\u0131rken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131n, dolar maliyet ortalamas\u0131 yap\u0131n, fiyat uyar\u0131lar\u0131 kurun ve klinik geli\u015fmeleri takip edin. Sab\u0131rl\u0131 olmak \u00f6nemlidir."},{"question":"IDEAYA Biosciences'in uzun vadeli fiyat hedefleri nelerdir?","answer":"Analistlere g\u00f6re 2025 sonunda 30-35 $, 2026'da 45-50 $, 2028'de 60-70 $ ve 2030'da 70-85 $ aral\u0131\u011f\u0131nda fiyat hedefleri bulunmaktad\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"IDEAYA Biosciences hisseleri nereden al\u0131nabilir?","answer":"IDEAYA Biosciences hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden IDYA sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"IDEAYA Biosciences hissesi i\u00e7in riskler nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131, d\u00fczenleyici onay gecikmeleri, piyasa volatilitesi ve sekt\u00f6rdeki rekabet yer almaktad\u0131r."},{"question":"IDEAYA Biosciences'in finansal durumu nas\u0131l?","answer":"\u015eirketin 1,05 milyar $ nakit pozisyonu bulunmakta olup, bu finansal istikrar 2029 y\u0131l\u0131na kadar operasyonlar\u0131 desteklemektedir."},{"question":"Yeni ba\u015flayan biri IDEAYA hissesi al\u0131rken nelere dikkat etmeli?","answer":"K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131n, dolar maliyet ortalamas\u0131 yap\u0131n, fiyat uyar\u0131lar\u0131 kurun ve klinik geli\u015fmeleri takip edin. Sab\u0131rl\u0131 olmak \u00f6nemlidir."},{"question":"IDEAYA Biosciences'in uzun vadeli fiyat hedefleri nelerdir?","answer":"Analistlere g\u00f6re 2025 sonunda 30-35 $, 2026'da 45-50 $, 2028'de 60-70 $ ve 2030'da 70-85 $ aral\u0131\u011f\u0131nda fiyat hedefleri bulunmaktad\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>IDEAYA Biosciences, Inc. (IDYA) Hisseleri Nas\u0131l Al\u0131n\u0131r - IDEAYA Biosciences, Inc. (IDYA) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IDEAYA Biosciences, Inc. (IDYA) Hisseleri Nas\u0131l Al\u0131n\u0131r - IDEAYA Biosciences, Inc. (IDYA) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T12:01:13+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"IDEAYA Biosciences, Inc. (IDYA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; IDEAYA Biosciences, Inc. (IDYA) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-28T12:01:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/\",\"name\":\"IDEAYA Biosciences, Inc. (IDYA) Hisseleri Nas\u0131l Al\u0131n\u0131r - IDEAYA Biosciences, Inc. (IDYA) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"datePublished\":\"2025-08-28T12:01:13+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IDEAYA Biosciences, Inc. (IDYA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; IDEAYA Biosciences, Inc. (IDYA) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"IDEAYA Biosciences, Inc. (IDYA) Hisseleri Nas\u0131l Al\u0131n\u0131r - IDEAYA Biosciences, Inc. (IDYA) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/","og_locale":"tr_TR","og_type":"article","og_title":"IDEAYA Biosciences, Inc. (IDYA) Hisseleri Nas\u0131l Al\u0131n\u0131r - IDEAYA Biosciences, Inc. (IDYA) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T12:01:13+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"IDEAYA Biosciences, Inc. (IDYA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; IDEAYA Biosciences, Inc. (IDYA) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-28T12:01:13+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/","name":"IDEAYA Biosciences, Inc. (IDYA) Hisseleri Nas\u0131l Al\u0131n\u0131r - IDEAYA Biosciences, Inc. (IDYA) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","datePublished":"2025-08-28T12:01:13+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals13.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-ideaya-biosciences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"IDEAYA Biosciences, Inc. (IDYA) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; IDEAYA Biosciences, Inc. (IDYA) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":354315,"slug":"how-to-buy-ideaya-biosciences","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu IDEAYA Biosciences, Inc. (IDYA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu IDEAYA Biosciences, Inc. (IDYA)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-ideaya-biosciences\/"},"pt_AA":{"locale":"pt_AA","id":354309,"slug":"how-to-buy-ideaya-biosciences","post_title":"Como comprar a\u00e7\u00f5es da IDEAYA Biosciences, Inc. (IDYA) - Investimento em a\u00e7\u00f5es da IDEAYA Biosciences, Inc. (IDYA)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-ideaya-biosciences\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354311","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=354311"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354311\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334099"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=354311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=354311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=354311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}